Ocular Therapeutix Inc (NAS:OCUL)
$ 5.8 -0.2 (-3.33%) Market Cap: 898.36 Mil Enterprise Value: 520.85 Mil PE Ratio: 0 PB Ratio: 2.20 GF Score: 78/100

Ocular Therapeutix Inc Annual Shareholders Meeting Transcript

Jun 25, 2020 / 12:30PM GMT
Release Date Price: $8.75 (+0.57%)
Operator

Good morning, ladies and gentlemen, and welcome to the Ocular Therapeutix, Inc.'s 2020 Annual Meeting of Stockholders.

I would like to introduce you to Mr. Charles Warden, Chairman of the Board of Ocular Therapeutics, Inc. Mr. Warden, you may begin.

Charles M. Warden
Ocular Therapeutix, Inc. - Independent Chairman

Good morning, and welcome to the 2020 Annual Meeting of Stockholders of Ocular Therapeutix. I am Charles Warden, Chairman of the Board of Directors of Ocular Therapeutix, and I will be presiding over this meeting. I welcome you and call the meeting to order.

Due to the public health impact of the COVID-19 pandemic and to support the health and well-being of our stockholders, employees and communities, this year, we are holding our annual meeting in an all-virtual format and are pleased to have everyone join this live broadcast. We have designed this meeting to provide stockholders the same rights and opportunities to participate as they would at an in-person meeting.

Before we get to the formal business of the meeting, I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot